Aurobindo Pharma Limited, a pharmaceutical company, has recently commissioned four state-of-the-art manufacturing facilities through its subsidiaries, each located strategically in Andhra Pradesh, India. 

Lyfius Pharma Private Limited, situated in the Kakinada SEZ area of Thondangi Mandal, Kakinada District, boasts an annual production capacity of 15,000 metric tons (MT) of Penicillin-G (Pen-G) and 1,80,000 MT of Glucose. With a market reach spanning captive use, domestic supply, and exports, Lyfius Pharma is poised to cater to diverse demands in the pharmaceutical sector.

Similarly, Qule Pharma Private Limited, also located in the Kakinada SEZ area, will produce 6-Amino Penicillanic Acid (6-APA). The facility possesses a substantial annual production capacity of 3,600 MT.

Moving on to Eugia Steriles Private Limited, based in Tadi Village, Parawada Mandal, Anakapalli District, the focus lies on the production of vials and ampoules. With an annual production capacity of 285 million units, Eugia Steriles primarily targets the export market, contributing to the global supply chain of pharmaceutical products.

Lastly, Auroactive Pharma Private Limited, nestled in Sancham Village, Ranasthalam Mandal, Srikakulam District, focuses on the production of granulated products ready for compression. With an annual production capacity of 13,200 MT, this facility serves a diverse market encompassing captive use, domestic supply, and exports.

These facilities have commenced commercial production of their respective products and have already made commercial sales to customers based on received purchase orders. It is anticipated that the revenues and profitability of these entities will experience growth over time as they ramp up their operations and cater to both domestic and international markets.